{
  "ticker": "VTVT",
  "company_name": "vTv Therapeutics Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT02405260",
      "title": "Add Glucokinase Activator to Target A1c",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Diabetes Mellitus, Type 2",
      "start_date": "2015-03",
      "completion_date": "2016-09",
      "enrollment": 0,
      "sponsor": "vTv Therapeutics"
    },
    {
      "nct_id": "NCT02080364",
      "title": "Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Alzheimer's Disease",
      "start_date": "2015-04",
      "completion_date": "2018-06-01",
      "enrollment": 0,
      "sponsor": "vTv Therapeutics"
    },
    {
      "nct_id": "NCT03980730",
      "title": "Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Alzheimer Disease",
      "start_date": "2019-06-27",
      "completion_date": "2021-01-29",
      "enrollment": 0,
      "sponsor": "vTv Therapeutics"
    },
    {
      "nct_id": "NCT00909298",
      "title": "Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA)",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Coagulation",
      "start_date": "2009-06",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "vTv Therapeutics"
    },
    {
      "nct_id": "NCT01665352",
      "title": "A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Type 2 Diabetes Mellitus",
      "start_date": "2012-08",
      "completion_date": "2013-05",
      "enrollment": 0,
      "sponsor": "vTv Therapeutics"
    },
    {
      "nct_id": "NCT02916056",
      "title": "2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Alzheimer's Disease",
      "start_date": "2016-12",
      "completion_date": "2018-06-01",
      "enrollment": 0,
      "sponsor": "vTv Therapeutics"
    },
    {
      "nct_id": "NCT01474083",
      "title": "A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Type 2 Diabetes Mellitus",
      "start_date": "2011-11",
      "completion_date": "2012-09",
      "enrollment": 0,
      "sponsor": "vTv Therapeutics"
    },
    {
      "nct_id": "NCT00119457",
      "title": "Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Venous Thromboembolism, Embolism and Thrombosis, Hip Fractures",
      "start_date": "2005-01",
      "completion_date": "2006-04",
      "enrollment": 0,
      "sponsor": "vTv Therapeutics"
    },
    {
      "nct_id": "NCT00779519",
      "title": "Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight Loss",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Obesity",
      "start_date": "2009-02",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "vTv Therapeutics"
    },
    {
      "nct_id": "NCT00939172",
      "title": "TTP607 in Refractory Solid Malignancies",
      "status": "WITHDRAWN",
      "phase": "PHASE1",
      "condition": "Advanced Cancers, Lymphoma",
      "start_date": "2010-03",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "M.D. Anderson Cancer Center"
    }
  ],
  "summary": {
    "total_trials": 14,
    "by_phase": {
      "PHASE2": 7,
      "PHASE3": 3,
      "PHASE1, PHASE2": 2,
      "PHASE1": 2
    },
    "by_status": {
      "COMPLETED": 8,
      "TERMINATED": 4,
      "WITHDRAWN": 1,
      "RECRUITING": 1
    },
    "active_trials": 1,
    "completed_trials": 8,
    "conditions": [
      "Advanced Cancers, Lymphoma",
      "Alzheimer Disease",
      "Alzheimer's Disease",
      "Coagulation",
      "Diabetes Mellitus, Type 1",
      "Diabetes Mellitus, Type 2",
      "Obesity",
      "Type 2 Diabetes Mellitus",
      "Venous Thromboembolism, Embolism and Thrombosis, Hip Fractures"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:36:15.814980",
    "search_query": "vTv Therapeutics Inc.",
    "url": "https://clinicaltrials.gov/search?term=vTv+Therapeutics+Inc."
  }
}